Director, Drug Safety (Pharmacovigilance)

Location: Onsite – Brisbane, California, United States

Salary: $247,300–$280,400 for non-MD candidates; $295,000–$317,100 for MD candidates. The posted range applies to roles based in the San Francisco Bay Area.

Company

hirify.global is a clinical-stage biopharmaceutical company developing targeted protein degradation medicines for cancer and inflammatory diseases, supported by an AI-integrated discovery engine.

What you will do

• Lead medical safety strategy and aggregate safety analysis for assigned clinical programs.
• Evaluate safety signals, characterize risks, and contribute to benefit–risk assessments.
• Oversee medical review of Individual Case Safety Reports and prepare DSURs, IND safety sections, and regulatory briefing materials.
• Provide safety input into clinical trial protocols, informed consent forms, and investigator brochures.
• Support regulatory authority responses, inspections, audits, and global safety strategy.
• Participate in safety governance committees and collaborate across clinical development, regulatory affairs, and medical affairs.

Requirements

• Advanced clinical or scientific degree such as MD, DO, PharmD, or equivalent relevant training and experience.
• 5–10 years of pharmaceutical or biotechnology experience in pharmacovigilance or drug safety.
• Expertise in aggregate safety analysis and benefit–risk evaluation.
• Knowledge of global pharmacovigilance regulations and guidance, including ICH, FDA, EMA, and MHRA.
• Experience with early clinical development, safety surveillance tools and databases, and global health authority interactions.
• Ability to work onsite in Brisbane, California.

Culture & Benefits

• Highly collaborative, team-oriented working environment.
• Solutions- and results-oriented approach.
• Hands-on, resourceful culture open to diverse points of view.
• Opportunity to influence safety decisions for targeted protein degradation therapies across the clinical pipeline.